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Introduction
Uveitis is an inflammation of the vascular tunic of the
eye (uvea), usually idiopathic, infectious or related to a
rheumatologic disease. In children it is a responsible for
more than 17% of unilateral legal blindness.
Purpose
To investigate the distribution, clinical features, compli-
cations and loss of visual acuity in paediatric uveitis in
the French speaking part of Switzerland treated accord-
ing to a multidisciplinary approach.
Methods
Retrospective cohort study of all patients diagnosed with
uveitis under the age of 16 years presenting to two ter-
tiary referral centres in Lausanne (uveitis and paediatric
rheumatology clinics), between 2000 and 2009.
Results
79 children (37 girls) were identified, 62 lived in Swit-
zerland, 11 in Italy. Mean age at first symptoms was
9.0 years (1.5-15.8 years) with a mean follow-up time
of 1.9 years (0-8 years). 51 had involvement of both
eyes (64.6%). The course was acute in 26.5%, chronic
in 51.9%, recurrent in 8.9% and not specified in 12.7%.
Anterior uveitis occurred in4 0 . 5 % ,i n t e r m e d i a t ei n
32.9%, posterior in 25.3% and panuveitis in 6.3%. The
three main diagnoses were idiopathic uveitis (34.2%),
juvenile idiopathic arthritis-related (22.8%) and toxo-
plasmosis (15.2%). More than the half of the patients
was treated with systemic therapies: corticosteroids 39,
methotrexate 17, azathioprine 11, cyclosporine 4 and
biotherapies 13. The visual acuity of most patients
remained stable (37.5%), or improved (36.3%) during
the follow-up. Only 7.5% eyes had a loss of visual
acuity (one or more lines) during the follow-up. 26.3%
patients presented one or more ocular complications.
The two commonest were cataract (12.5%) and ocular
hypertension (10%).
Conclusion
Our patients show a better visual outcome than pre-
viously published cohorts. Thus, early recognition and
prompt and aggressive treatment are essential to reduce
the rate of complications and improve the visual out-
come. Collaboration between ophthalmologists and
rheumatologists enables a better management of sys-
temic treatments and prompt access to immunosuppres-
sive agents and biotherapies.
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